Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Therapeutic Drug Monitoring|June 10, 2025
The Rational Basis for Personalized Treatment Using Concentration-Guided DosingNick Holford, Zvonimir PetricPharmaceutics|September 23, 2022
Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of BiosimilarsZvonimir Petric, Joao Goncalves, Paulo PaixaoActa Pharmaceutica (Zagreb, Croatia)|July 23, 2020
The controversies of parabens - an overview nowadaysZvonimir Petric, Julia Ružić, Irena ŽuntarBiomedicines|September 28, 2024
Infliximab in Inflammatory Bowel Disease: Leveraging Physiologically Based Pharmacokinetic Modeling in the Clinical ContextZvonimir Petric, João Gonçalves, Paulo PaixãoPharmaceutics|March 27, 2025
Physiologically Based Biopharmaceutics Model of Apixaban for Biopharmaceutics Risk AssessmentPaulo Paixão, Zvonimir Petric, José A G MoraisFoods (Basel, Switzerland)|December 30, 2020
Food-Drug Interactions with Fruit JuicesZvonimir Petric, Irena Žuntar, Predrag Putnik, et al.Foods (Basel, Switzerland)|July 26, 2020
Safety of Probiotics: Functional Fruit Beverages and NutraceuticalsIrena Žuntar, Zvonimir Petric, Danijela Bursać Kovačević, et al.Pharmaceutics|October 28, 2023
Clinical Pharmacology of Vinpocetine: Properties Revisited and Introduction of a Population Pharmacokinetic Model for Its Metabolite, Apovincaminic Acid (AVA)Zvonimir Petric, Paulo Paixão, Augusto Filipe, et al.Pharmaceutics|May 25, 2024
A Two-Way Proposal for the Determination of Bioequivalence for Narrow Therapeutic Index Drugs in the European UnionPaulo Paixao, Alfredo Garcia Arieta, Nuno Silva, et al.Pageof 1